Pinned Tweet
Exploring advances in Cancer Therapeutics, Targets & Resistance from Acta Materia Medica
Discover cutting-edge research: amm-journal.org/
#CancerResearch #CancerTherapeutics #DrugResistance #Oncology
Acta Materia Medica retweeted
Postdoc in Medicinal Chemistry of Host-Targeting Anti-Viral Agents at DTU Chemistry, Denmark
Technical University of Denmark (DTU) Chemistry is seeking a talented and motivated postdoc to drive the search for new anti-viral agents, specifically focused
researchersjob.com/postdoc-i…
Acta Materia Medica retweeted
TODAY IS THE LAST DAY FOR ABSTRACT SUBMISSION!
Join the 18th International Conference & Exhibition on Pharmacology, Drug Discovery & Pharmacotherapy.
Date: December 08–09, 2026
Kuala Lumpur, Malaysia
Submit Your Abstract:
pharmacy.ucgconferences.com/…
WhatsApp: +971551792927
🤖 Made with AI

ALT TODAY IS THE LAST DAY FOR ABSTRACT SUBMISSION! Join the 18th International Conference & Exhibition on Pharmacology, Drug Discovery & Pharmacotherapy. Date: December 08–09, 2026 Location: Kuala Lumpur, Malaysia Abstract Deadline: November 15, 2026 Present your research, share your innovations, and connect with global experts. Submit Your Abstract: https://pharmacy.ucgconferences.com/submit-abstract WhatsApp: +971551792927 #PharmaUCG2026 #Pharmacology #DrugDiscovery #Pharmacotherapy #AbstractSubmission #PharmaConference #MedicalResearch
Acta Materia Medica retweeted
Replying to @Bayer
@Bayer Foundation Fellowship
scientific fellowships for outstanding master, PhD, and medical students to pursue international research projects, internships in Agriculture, Medical, Climate & Health and Drug Discovery
Details at bayer-foundation.com/en/scie…
Apply by 18th January 2027
A Caryota maxima extract extended lifespan in C. elegans through DAF-2 signaling and MUFA-dependent metabolic regulation, with rutin reproducing key geroprotective effects. #Geroscience #Celegans
#AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
Acta Materia Medica retweeted
Submit your nomination for the following Lectureships and Awards by Tuesday, 1 December:
🌟 Philip S. Portoghese Medicinal Chemistry Lectureship
🌟 ACS Infectious Diseases Early Career Award
🌟 ACS Synthetic Biology Early Career Innovator Award
go.acs.org/eYd
Acta Materia Medica retweeted
📢 FULLY FUNDED 4-YEAR PHD POSITION IN MEDICINAL CHEMISTRY AND CHEMICAL BIOLOGY (START 2027)
🔬 Project: Chemically induced proximity for targeted therapies against cancer and progeria, using chemical proteomics, E3 ligase validation, and PROTAC development
🧑🎓 Universidad Complutense de Madrid, Spain
🥼 Medicinal Chemistry Laboratory (Prof. Silvia Ortega Gutiérrez), Department of Organic Chemistry
🚨 Requirements: Bachelor's and Master's degrees in chemistry (300 credits total). Strong foundation in organic chemistry, synthesis, and structural elucidation.
📅 Deadline: 4 December 2026
🚨 Apply now: send CV with transcripts and two references' contact details to [email protected], and apply via the UCM online platform
Acta Materia Medica retweeted
A #pharmacogenomics analysis of 100,000 participants in the @AllofUsResearch program sheds light on the landscape of pharmacogene variants in diverse ancestries and tackles gaps in genomics knowledge in underrepresented groups. @ScienceTM scim.ag/3UJEKUL
This review examines how androgen receptor alterations contribute to CRPC and discusses PROTACs as tools for degrading proteins that sustain disease progression and therapeutic resistance. #CancerBiology #ProstateCancer @harvardmed
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
Acta Materia Medica retweeted
This review examines how androgen receptor alterations contribute to CRPC and discusses PROTACs as tools for degrading proteins that sustain disease progression and therapeutic resistance. #CancerBiology #ProstateCancer @harvardmed
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
A randomized trial found that Cs4 improved symptom severity, fatigue, insomnia, respiratory symptoms, and quality of life over 12 weeks in patients with long COVID. #ClinicalTrials #CordycepsSinensis @HKUniversity
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
Check the full article here👇
scienceopen.com/hosted-docum…
1
6
Acta Materia Medica retweeted
A randomized trial found that Cs4 improved symptom severity, fatigue, insomnia, respiratory symptoms, and quality of life over 12 weeks in patients with long COVID. #ClinicalTrials #CordycepsSinensis @HKUniversity
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
Acta Materia Medica retweeted
💊 Not every disease-associated molecular change is a promising drug target.
In @DrugTargetRev , our Dr Shi-qi An explores how multiomics, single-cell and spatial technologies can strengthen drug target discovery.
🔗 drugtargetreview.com/home/ho…
Acta Materia Medica retweeted
Be Part of the Future of Pharmacology
Join PHARMAUE 2026 – 18th International Conference & Exhibition on Pharmacology, Drug Discovery & Pharmacotherapy.
Date: 8–9 December 2026
Venue: Kuala Lumpur, Malaysia & Virtual
Register Now: pharmacy.ucgconferences.com/…
This review highlights microneedles as a user-friendly strategy for enhancing transdermal insulin transport while overcoming gastrointestinal and skin barriers. #Pharmaceutics #DrugDelivery
#AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
2
31
Acta Materia Medica retweeted
Join us at these upcoming conferences:
- Drug Discovery Chemistry Europe, November 10-12, Barcelona, Spain
drugdiscoverychemistry.com/e…
- The 43rd Medicinal Chemistry Symposium, November 11-13, Kyoto, Japan
k-gakkai.jp/mcs2026/en/en_in…
We will be happy to meet you, discuss the latest developments in Drug Discovery, and explore new opportunities for collaboration.
Acta Materia Medica retweeted
🇳🇱 Leiden University — PhD in AI-Driven Drug Discovery
🔥 URGENT | MSCA-Funded | Deadline: November 12, 2026
🏫 University: Leiden University
🔬 Laboratory: Leiden Academic Centre for Drug Research (LACDR) — Computational Drug Discovery Group
📍 Location: Leiden, Netherlands
🆕 Published: October 15, 2026
📖 Research Project:
ANA-KIN DC10 — Deep Learning for Kinase Drug Discovery
This PhD focuses on developing artificial intelligence models to discover new cancer therapeutics targeting protein kinases.
Unlike conventional kinase inhibitors, which primarily target ATP-binding sites, the project investigates alternative regulatory interfaces to improve drug selectivity and overcome resistance.
Research Activities:
•Develop deep-learning models for kinase inhibitor discovery.
•Integrate chemical, structural, and biophysical datasets.
•Predict molecular binding and drug-resistance mechanisms.
•Design computational approaches for peptide-based therapeutics.
•Apply AI models to experimental drug-discovery workflows.
•Develop open-source computational tools.
The position includes research secondments at two Belgian partner organizations.
💰 Funding Details:
✅ Fully funded through the Horizon Europe MSCA Doctoral Network ANA-KIN.
✅ Four-year salaried PhD position.
✅ Gross monthly salary: €3,204–€4,051.
✅ Additional 8% holiday allowance.
✅ Additional 8.3% year-end allowance.
✅ University pension and employment benefits.
✅ International research secondments and specialist training.
Contract Structure: Initial one-year appointment, extendable for the remaining three years after a positive evaluation.
🔍 Application Requirements:
•Master’s degree in Computer Science, AI, Computational Chemistry, Bioinformatics, or a related field.
•Experience with machine learning and deep learning, preferably PyTorch.
•Knowledge of cheminformatics or computational chemistry.
•Excellent Python programming skills.
•Strong academic English.
•Interest in pharmaceutical research.
MSCA Eligibility:
•Applicants must not already hold a doctoral degree.
•Applicants must not have lived, worked, or studied in the Netherlands for more than 12 months during the preceding 36 months, subject to MSCA exceptions.
Required Documents:
•Motivation letter confirming MSCA eligibility.
•Academic CV.
•Academic grade list.
•Contact details of two referees.
🕒 Application Deadline: November 12, 2026.
⏳ Time Remaining: 4 Days!
⭐ Why Apply?
This is an excellent opportunity to combine artificial intelligence with pharmaceutical research.
The project offers a competitive Dutch salary, international research experience, and collaboration with academic and industrial partners.
🔗 Official University Application:
careers.universiteitleiden.n…
#phd #PhD #phdopportunity #phdposition
Acta Materia Medica retweeted
POSTDOCTORAL FELLOWSHIPS IN MEDICINAL CHEMISTRY AT UNIVERSITY OF CAPE TOWN
👇👇👇👇👇👇👇👇
@PostdocPhd @PostdocO
The multidimensional biology of SKP2: mechanisms, pathologies, and emerging therapeutic frontiers. Click the link below to read this #open_access article. scienceopen.com/hosted-docum…
17























